Kinsey, E., Brown, L., Kao, C., Healy, P., Harrison, M., McNamara, M., … Zhang, T. (2019). Combination cabozantinib and nivolumab treatment in patients with refractory metastatic renal cell carcinoma (mRCC). In JOURNAL FOR IMMUNOTHERAPY OF CANCER (Vol. 7). BMC.

Kinsey, Emily, Landon Brown, Chester Kao, Patrick Healy, Michael Harrison, Megan McNamara, Andrew Armstrong, Sundhar Ramalingham, Daniel George, and Tian Zhang. “Combination cabozantinib and nivolumab treatment in patients with refractory metastatic renal cell carcinoma (mRCC).” In JOURNAL FOR IMMUNOTHERAPY OF CANCER, Vol. 7. BMC, 2019.

Kinsey E, Brown L, Kao C, Healy P, Harrison M, McNamara M, et al. Combination cabozantinib and nivolumab treatment in patients with refractory metastatic renal cell carcinoma (mRCC). In: JOURNAL FOR IMMUNOTHERAPY OF CANCER. BMC; 2019.

Kinsey, Emily, et al. “Combination cabozantinib and nivolumab treatment in patients with refractory metastatic renal cell carcinoma (mRCC).” JOURNAL FOR IMMUNOTHERAPY OF CANCER, vol. 7, BMC, 2019.

Kinsey E, Brown L, Kao C, Healy P, Harrison M, McNamara M, Armstrong A, Ramalingham S, George D, Zhang T. Combination cabozantinib and nivolumab treatment in patients with refractory metastatic renal cell carcinoma (mRCC). JOURNAL FOR IMMUNOTHERAPY OF CANCER. BMC; 2019.